These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3056889)

  • 1. Management of bleeding in the patient receiving thrombolytic therapy for acute myocardial infarction: a nursing perspective.
    Kline E
    Heart Lung; 1988 Nov; 17(6 Pt 2):771-7. PubMed ID: 3056889
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary thrombolysis: hemorrhagic complications.
    Hirsh J
    Can J Cardiol; 1993; 9(6):505-11. PubMed ID: 8221344
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombolytic treatment of acute myocardial infarct. 2].
    Soares-Costa TJ; Gabriel HM; Soares-Costa JT
    Acta Med Port; 1998 May; 11(5):421-9. PubMed ID: 9951052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nursing care of the patient receiving thrombolytic therapy.
    Magee M
    J Emerg Nurs; 1989; 15(2( Pt 2)):165-73. PubMed ID: 2649730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct].
    Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C
    An Med Interna; 1997 Apr; 14(4):209. PubMed ID: 9181820
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic therapy for venous thromboembolism. Complications and contraindications.
    Levine MN
    Clin Chest Med; 1995 Jun; 16(2):321-8. PubMed ID: 7656543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fever after an acute myocardial infarct].
    Castro A; Antorrena I; González C
    Rev Esp Cardiol; 1999 Dec; 52(12):1146-7. PubMed ID: 10659660
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety profile of thrombolytic drugs.
    Maggioni AP; Fresco C
    Arq Bras Cardiol; 1995 Jul; 65(1):87-90. PubMed ID: 8546604
    [No Abstract]   [Full Text] [Related]  

  • 9. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 10. How have trials of thrombolytics influenced clinical management of patients with acute myocardial infarction.
    Marder VJ
    Thromb Haemost; 1997 Jul; 78(1):548-52. PubMed ID: 9198213
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of thrombolytic therapy in acute myocardial infarction.
    Bradbury M; Cruickshank JP
    Br J Nurs; 1993 Jun 24-Jul 7; 2(12):619-24. PubMed ID: 8348005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What should a new thrombolytic bring us?
    Verheugt F
    Int J Clin Pract Suppl; 1998 Nov; 99():3-5. PubMed ID: 10344033
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.
    Levine MN; Goldhaber SZ; Gore JM; Hirsh J; Califf RM
    Chest; 1995 Oct; 108(4 Suppl):291S-301S. PubMed ID: 7555183
    [No Abstract]   [Full Text] [Related]  

  • 14. Formulating appropriate nursing diagnoses for the patient receiving tissue-type plasminogen activator.
    Brooks-Brunn JA
    Heart Lung; 1987 Nov; 16(6 Pt 2):787-91. PubMed ID: 3119523
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravenous thrombolytic therapy in myocardial infarction (review)].
    Staroverov II
    Ter Arkh; 2003; 75(10):80-3. PubMed ID: 14669614
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes.
    Rao SV; O'Grady K; Pieper KS; Granger CB; Newby LK; Mahaffey KW; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Harrington RA
    J Am Coll Cardiol; 2006 Feb; 47(4):809-16. PubMed ID: 16487850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient selection issues in the use of thrombolytic therapy in patients with acute myocardial infarction.
    Gore JM
    Z Kardiol; 1993; 82 Suppl 2():143-6. PubMed ID: 8328193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bolus fibrinolysis in acute myocardial infarction].
    Zeymer U
    Dtsch Med Wochenschr; 2002 Oct; 127(40):2083-6. PubMed ID: 12373644
    [No Abstract]   [Full Text] [Related]  

  • 19. Bleeding complications in the patient with cardiac disease following thrombolytic and anticoagulant therapies.
    Dunn SM; Senerchia CB
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):511-23. PubMed ID: 8217046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.